Qingyang Shi

Years Active: 2023-2023
Publications (10 Years): 1

This page only lists publications with an associated author ORCID identifier.

Publications

Qingyang Shi, Kailei Nong, Per Olav Vandvik, Gordon H Guyatt, Oliver Schnell, Lars Rydén, Nikolaus Marx, Frank C Brosius, Reem A Mustafa, Arnav Agarwal, Xinyu Zou, Yunhe Mao, Aminreza Asadollahifar, Saifur Rahman Chowdhury, Chunjuan Zhai, Sana Gupta, Ya Gao, João Pedro Lima, Kenji Numata, Zhi Qiao, Qinlin Fan, Qinbo Yang, Yinghui Jin, Long Ge, Qiuyu Yang, Hongfei Zhu, Fan Yang, Zhe Chen, Xi Lu, Siyu He, Xiangyang Chen, Xiafei Lyu, Xingxing An, Yaolong Chen, Qiukui Hao, Eberhard Standl, Reed Siemieniuk, Thomas Agoritsas, Haoming Tian, Sheyu Li
Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials. BMJ (Clinical research ed.) 381 (2023)

Qingyang Shi.css-eqlu8i{font-size:small;padding-left:4px;}